Effect of Omega-3 Supplementation on Major Adverse Cardiovascular Events (MACE): A Systematic Review

Annesyia Aisy, Meriza Martineta, Dina Keumala Sari, Esther Reny Deswani Sitorus

Abstract


Abstract: Major adverse cardiovascular events (MACE) are the most relevant outcome in cardiovascular secondary prevention because they are the main cause of mortality and morbidity in patients with cardiovascular disease. Due to the contrasting results between studies, omega-3 supplementation is believed to have cardioprotective effects, but its significance in reducing MACE is still in question. This study aims to determine the effect of omega-3 supplementation on the prevention of MACE. A literature search was carried out on several databases from September 820, 2021. Selection of literature is done through the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart. Literature that is eligible was then assessed qualitatively. We compared the hazard ratio of each key outcome of interest, which was included in the primary and secondary end-point of each study. Among 2049 publications found from the initial literature search, 6 publications were included in this study. The analysis showed a significant reduction in cardiovascular risk in participants with a high dose of pure EPA. Studies with a lower dose of omega-3 that contains a combination of EPA and DHA did not provide similar significant results. The use of high-dose omega-3 supplementation with pure EPA content can significantly reduce

Keywords


Major adverse cardiovascular events, omega-3, systematic review

Full Text:

PDF

References


ASCEND Study Collaborative Group. Effects of n? 3 fatty acid supplements in diabetes mellitus. New England Journal of Medicine. 2018 Oct 18;379(16):1540-50.

Baird R. Systematic reviews and meta-analytic techniques. InSeminars in pediatric surgery 2018 Dec 1 (Vol. 27, No. 6, pp. 338-344). WB Saunders.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle Jr RT, Juliano RA, Jiao L, Granowitz C, Tardif JC. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine. 2019 Jan 3;380(1):11-22.

Chaddha A, Eagle KA. Omega-3 fatty acids and heart health. Circulation. 2015 Dec 1;132(22):e350-2.

Chen HY, Gore JM, Lapane KL, Yarzebski J, Person SD, Gurwitz JH, Kiefe CI, Goldberg RJ. A 35-year perspective (1975 to 2009) into the long-term prognosis and hospital management of patients discharged from the hospital after a first acute myocardial infarction. The American journal of cardiology. 2015 Jul 1;116(1):24-9.

Choi BG, Rha SW, Yoon SG, Choi CU, Lee MW, Kim SW. Association of major adverse cardiac events up to 5 years in patients with chest pain without significant coronary artery disease in the Korean population. Journal of the American Heart Association. 2019 Jun 18;8(12):e010541.

Elagizi A, Lavie CJ, OKeefe E, Marshall K, OKeefe JH, Milani RV. An update on omega-3 polyunsaturated fatty acids and cardiovascular health. Nutrients. 2021 Jan;13(1):204.

Fumagalli M, Moltke I, Grarup N, Racimo F, Bjerregaard P, Jrgensen ME, Korneliussen TS, Gerbault P, Skotte L, Linneberg A, Christensen C. Greenlandic Inuit show genetic signatures of diet and climate adaptation. Science. 2015 Sep 18;349(6254):1343-7.

Innes JK, Calder PC. The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiometabolic risk factors: a systematic review. International journal of molecular sciences. 2018 Feb;19(2):532.

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DW, Tveit A, Fagerland MW, Solheim S, Seljeflot I. Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial. Circulation. 2021 Feb 9;143(6):528-39.

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, DAgostino D. Marine n? 3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine. 2019 Jan 3;380(1):23-32.

Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJ, Koenig W, McGuire DK, Mozaffarian D. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. Jama. 2020 Dec 8;324(22):2268-80.

ORIGIN Trial Investigators. n3 Fatty acids and cardiovascular outcomes in patients with dysglycemia. New England Journal of Medicine. 2012 Jul 26;367(4):309-18.

Piironen M, Ukkola O, Huikuri H, Havulinna AS, Koukkunen H, Mustonen J, Ketonen M, Lehto S, Airaksinen J, Antero Kesniemi Y, Salomaa V. Trends in long-term prognosis after acute coronary syndrome. European journal of preventive cardiology. 2017 Feb 1;24(3):274-80.

Sacks FM, Lichtenstein AH, Wu JH, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2017 Jul 18;136(3):e1-23.

Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem Jr N. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progress in lipid research. 2016 Jul 1;63:132-52.

Udani JK, Ritz BW. High potency fish oil supplement improves omega-3 fatty acid status in healthy adults: an open-label study using a web-based, virtual platform. Nutrition journal. 2013 Dec;12(1):1-5.




DOI: https://doi.org/10.30596/bf.v7i2.9038

DOI (PDF): https://doi.org/10.30596/bf.v7i2.9038.g8671

Refbacks

  • There are currently no refbacks.


JURNAL BULETIN FARMATERA

Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.

Contact (WA): 0812-6208-2844

E-mail: farmatera@umsu.ac.id


 
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Statcounter View My Stats Buletin Farmatera